Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 775


Tocopherols inhibit esophageal carcinogenesis through attenuating NF-κB activation and CXCR3-mediated inflammation.

Yang H, Xu M, Lu F, Zhang Q, Feng Y, Yang CS, Li N, Jia X.

Oncogene. 2018 Apr 17. doi: 10.1038/s41388-018-0246-8. [Epub ahead of print]


Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.

Recke A, Regensburger AK, Weigold F, Müller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G.

Front Immunol. 2018 Mar 22;9:428. doi: 10.3389/fimmu.2018.00428. eCollection 2018.


CXCR3<sup>+</sup> Monocytes Increase Significantly in Graft Blood Compared to Peripheral Blood in Patients With Stable Kidney Graft Function.

Caballero A, Palma E, Ruiz-Esteban P, Vazquez T, Sola E, Torio A, Cabello M, Lopez V, Jironda C, Duarte A, Alonso-Titos J, Hernández D.

Transplant Proc. 2018 Mar;50(2):555-559. doi: 10.1016/j.transproceed.2017.11.055.


Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger AK, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G.

Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8.


Neonatal hyperglycemia induces CXCL10/CXCR3 signaling and microglial activation and impairs long-term synaptogenesis in the hippocampus and alters behavior in rats.

Satrom KM, Ennis K, Sweis BM, Matveeva TM, Chen J, Hanson L, Maheshwari A, Rao R.

J Neuroinflammation. 2018 Mar 15;15(1):82. doi: 10.1186/s12974-018-1121-9.


CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis.

Zhang Y, Xu L, Peng M.

Onco Targets Ther. 2018 Feb 27;11:1045-1054. doi: 10.2147/OTT.S157421. eCollection 2018.


Blood CXCR3<sup>+</sup> CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals.

Banga R, Procopio FA, Ruggiero A, Noto A, Ohmiti K, Cavassini M, Corpataux JM, Paxton WA, Pollakis G, Perreau M.

Front Immunol. 2018 Feb 5;9:144. doi: 10.3389/fimmu.2018.00144. eCollection 2018.


Th1, Th17, and Th1Th17 Lymphocytes during Tuberculosis: Th1 Lymphocytes Predominate and Appear as Low-Differentiated CXCR3<sup>+</sup>CCR6<sup>+</sup> Cells in the Blood and Highly Differentiated CXCR3<sup>+/-</sup>CCR6<sup>-</sup> Cells in the Lungs.

Nikitina IY, Panteleev AV, Kosmiadi GA, Serdyuk YV, Nenasheva TA, Nikolaev AA, Gorelova LA, Radaeva TV, Kiseleva YY, Bozhenko VK, Lyadova IV.

J Immunol. 2018 Mar 15;200(6):2090-2103. doi: 10.4049/jimmunol.1701424. Epub 2018 Feb 12.


Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?

Urra S, Fischer MC, Martínez JR, Véliz L, Orellana P, Solar A, Bohmwald K, Kalergis A, Riedel C, Corvalán AH, Roa JC, Fuentealba R, Cáceres CJ, López-Lastra M, León A, Droppelmann N, González HE.

Oncotarget. 2017 Dec 20;9(2):2445-2467. doi: 10.18632/oncotarget.23502. eCollection 2018 Jan 5.


The relationship between HDAC6, CXCR3, and SIRT1 genes expression levels with progression of primary open-angle glaucoma.

Siwak M, Maślankiewicz M, Nowak-Zduńczyk A, Rozpędek W, Wojtczak R, Szymanek K, Szaflik M, Szaflik J, Szaflik JP, Majsterek I.

Ophthalmic Genet. 2018 Jan 31:1-7. doi: 10.1080/13816810.2018.1432061. [Epub ahead of print]


Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway.

Liu H, Tian Q, Ai X, Qin Y, Cui Z, Li M, Yang J, Zhai D, Liu Y, Chen S, Meng J, Sun T, Zhou H, Yang C.

Oncotarget. 2017 Dec 1;8(70):115028-115040. doi: 10.18632/oncotarget.22854. eCollection 2017 Dec 29.


Role of the chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular recruitment of plasmacytoid dendritic cells in dermatomyositis.

Lv J, Li L, Li W, Ji K, Hou Y, Yan C, Dai T.

J Neuroimmunol. 2018 Jan 9. pii: S0165-5728(18)30015-8. doi: 10.1016/j.jneuroim.2018.01.008. [Epub ahead of print]


Disruption of CXCR3 function impedes the development of Sjögren's syndrome-like xerostomia in non-obese diabetic mice.

Zhou J, Yu Q.

Lab Invest. 2018 Jan 18. doi: 10.1038/s41374-017-0013-4. [Epub ahead of print]


Molecular Mechanisms of Biased and Probe-Dependent Signaling at CXC-Motif Chemokine Receptor CXCR3 Induced by Negative Allosteric Modulators.

Brox R, Milanos L, Saleh N, Baumeister P, Buschauer A, Hofmann D, Heinrich MR, Clark T, Tschammer N.

Mol Pharmacol. 2018 Apr;93(4):309-322. doi: 10.1124/mol.117.110296. Epub 2018 Jan 17.


CXCR3 ligands in pleural fluid as markers for the diagnosis of tuberculous pleural effusion.

Chung W, Jung Y, Lee K, Park J, Sheen S, Park K.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1300-1306. doi: 10.5588/ijtld.17.0232.


CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model.

Miao S, Tang B, Liu H, Wang Z, Shi Y, Dong Y, Liu W, Qin C, Ren H.

Mol Immunol. 2018 Feb;94:82-90. doi: 10.1016/j.molimm.2017.12.010. Epub 2017 Dec 27.


The Chemokine Receptor CXCR3 Promotes CD8<sup>+</sup> T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection.

Caldeira-Dantas S, Furmanak T, Smith C, Quinn M, Teos LY, Ertel A, Kurup D, Tandon M, Alevizos I, Snyder CM.

J Immunol. 2018 Feb 1;200(3):1133-1145. doi: 10.4049/jimmunol.1701272. Epub 2017 Dec 29.


Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma.

Li Z, Liu J, Li L, Shao S, Wu J, Bian L, He Y.

Oncol Rep. 2018 Mar;39(3):1356-1368. doi: 10.3892/or.2017.6169. Epub 2017 Dec 20.


HPV16E7-Induced Hyperplasia Promotes CXCL9/10 Expression and Induces CXCR3<sup>+</sup> T-Cell Migration to Skin.

Kuo P, Tuong ZK, Teoh SM, Frazer IH, Mattarollo SŒ, Leggatt GR.

J Invest Dermatol. 2017 Dec 23. pii: S0022-202X(17)33358-4. doi: 10.1016/j.jid.2017.12.021. [Epub ahead of print]


Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.

Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A.

Br J Pharmacol. 2018 May;175(9):1419-1438. doi: 10.1111/bph.14132. Epub 2018 Mar 23.


Supplemental Content

Support Center